NCT01737866View on ClinicalTrials.gov

Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency

PHASE1CompletedINTERVENTIONAL
Enrollment

13

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

May 31, 2013

Conditions
Heart Failure
Interventions
DRUG

AMG 423

omecamtiv mecarbil

Trial Locations (1)

32809

Research Site, Orlando

Sponsors

Lead Sponsor

Cytokinetics
All Listed Sponsors
lead

Cytokinetics

INDUSTRY

NCT01737866 - Pharmacokinetics Study of AMG 423 in Healthy Subjects and Subjects With Various Degrees of Renal Insufficiency | Biotech Hunter | Biotech Hunter